M

Mater Hospital Sydney | Patricia Ritchie Centre for Cancer Care and Research

Research site

(Unclaimed)

Location

25 Rocklands Road, North Sydney, New South Wales, Australia

Site insights

Top conditions

Top treatments

Letrozole

Anastrozole

Tamoxifen

Carboplatin

Trilaciclib

Exemestane

Palbociclib

Capivasertib

Gemcitabine

RLY-2608

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (ELEGANT)

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive,...

Enrolling

Breast Cancer

Drug: Elacestrant

Drug: Tamoxifen

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer (ReDiscover-2)

This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 + fulvestrant to capivasertib + ful...

Enrolling

Breast Cancer

PIK3CA Mutation

Drug: Capivasertib

Drug: RLY-2608